Omodenbamab immunoglobulin, designated with the code 2241724-48-9, constitutes a novel monoclonal antibody currently subject to investigation for: concerning its anticipated therapeutic applications: uses, specifically targeting adcy2. Researchers: Scientists intend to exploring its mechanism: mo